| Structure | Chemical Name | CAS | MF |
|
3-Pyridinecarboxamide,6-methyl-N-[(1R,2S)-2-phenylcyclopropyl]-,rel-(9CI)
|
658683-88-6
|
C16H16N2O
|
|
Pyrazinecarboxamide, 3-amino-N-[(1R,2S)-2-phenylcyclopropyl]-, rel- (9CI)
|
658683-92-2
|
C14H14N4O
|
|
2-Thiophenecarboxamide,5-methyl-N-[(1R,2S)-2-phenylcyclopropyl]-,rel-
|
658684-08-3
|
C15H15NOS
|
|
Benzamide, 4-fluoro-N-[(1R,2S)-2-phenylcyclopropyl]-, rel- (9CI)
|
658684-12-9
|
C16H14FNO
|
|
Benzamide, 4-fluoro-N-[(1R,2S)-2-phenylcyclopropyl]-, rel-(+)- (9CI)
|
658684-14-1
|
C16H14FNO
|
|
Benzamide, 4-fluoro-N-[(1R,2S)-2-phenylcyclopropyl]-, rel-(-)- (9CI)
|
658684-16-3
|
C16H14FNO
|
|
2(1H)-Quinoxalinethione,3-ethyl-(9CI)
|
658686-30-7
|
C10H10N2S
|
|
Quinoxaline, 2-ethyl-3-(methylthio)- (9CI)
|
658686-48-7
|
C11H12N2S
|
|
beta-Alanine, N-methyl-N-(1-oxo-2-propenyl)- (9CI)
|
658687-97-9
|
C7H11NO3
|
|
3-PIPERIDIN-1-YL-BENZOIC ACID ETHYL ESTER
|
658689-00-0
|
C14H19NO2
|
|
Benzoic acid, 3-[(1-methylethyl)amino]-, ethyl ester (9CI)
|
658689-17-9
|
C12H17NO2
|
|
METHYL 3-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZOATE
|
658689-29-3
|
C14H20N2O2
|
|
Benzoic acid, 3-(propylamino)-, ethyl ester (9CI)
|
658689-59-9
|
C12H17NO2
|
|
Cyclopentanecarboxylic acid, 2-methyl-, 3-methyl-2-butenyl ester, (1R,2R)-rel- (9CI)
|
658692-06-9
|
C12H20O2
|
|
Cyclopentanecarboxylic acid, 1-(1,1-dimethyl-2-propenyl)-2-methyl-, (1R,2S)-rel- (9CI)
|
658692-10-5
|
C12H20O2
|
|
4-Pyridinecarbonitrile, 2-chloro-3-(hydroxy-1-naphthalenylmethyl)-
|
658695-47-7
|
C17H11ClN2O
|
|
5-(1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-pyrrole-3-carboxylic acid
|
658695-85-3
|
C11H8N4O2
|
|
Ketone, hexahydro-1-hydroxy-1-indanyl hydroxymethyl (5CI)
|
658698-21-6
|
C11H18O3
|
|
Ketone, 1-hydroxy-2,2-dimethylcyclohexyl methyl (5CI)
|
658698-99-8
|
C10H18O2
|
|
Ketone, 1-hydroxy-1-indanyl hydroxymethyl (5CI)
|
658699-36-6
|
C11H12O3
|
|
Ketone, 5-hydroxy-4-indanyl methyl (5CI)
|
658699-37-7
|
C11H12O2
|
|
4-(2-FLUOROPHENYL)PYRIMIDIN-2-AMINE
|
658699-90-2
|
C10H8FN3
|
|
6,10-Dihydroxy Buspirone
|
658701-59-8
|
C21H31N5O4
|
|
Ethanone,1-(5-ethynyl-2-thienyl)-
|
658701-97-4
|
C8H6OS
|
|
Phenol, 2-(3-fluoropropyl)- (9CI)
|
658704-31-5
|
C9H11FO
|
|
ENDO-3-(4-METHYLBENZOYL)-7-OXABICYCLO[2.2.1]HEPTANE-EXO-2-CARBOXYLIC ACID
|
658704-71-3
|
C15H16O4
|
|
4H-Pyran-4-one,2-(4-ethylphenyl)-2,3-dihydro-,(-)-(9CI)
|
658704-85-9
|
C13H14O2
|
|
1H-2-Benzopyran-1-one,3-[(2R,3S)-3-ethyloxiranyl]-,rel-(9CI)
|
658707-12-1
|
C13H12O3
|
|
1H-Purine,6-ethyl-2-(trifluoromethyl)-(9CI)
|
658707-89-2
|
C8H7F3N4
|
|
1-Methyl-3-phenylpiperidine-4-carboxylic acid
|
658712-69-7
|
C13H17NO2
|
|
5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-PROPOINIC ACID
|
658712-81-3
|
C11H14N2O2
|
|
THP-PEG10
|
658858-65-2
|
C21H42O10
|
|
1,4-Dioxaspiro[4.5]dec-6-ene,2-ethyl-6-methyl-9-(1-methylethenyl)-,(9R)-(9CI)
|
659719-50-3
|
C14H22O2
|
|
Ketone, 2,4-dimethyl-3-thienyl methyl (5CI)
|
659719-92-3
|
C8H10OS
|
|
RALUFON (R) S 18-20
|
659720-02-2
|
|
|
|
LEVELER 135 CU
|
659720-03-3
|
|
|
[5-(Trifluoromethyl)pyridin-2-yl]tributylstannane
|
659722-71-1
|
C18H30F3NSn
|
|
1H-Benzimidazole-2-methanol,alpha-methyl-,(alphaR)-(9CI)
|
659724-77-3
|
C9H10N2O
|
|
Imidazo[1,2-a]pyrazine, 3-ethoxy-2-methyl- (9CI)
|
659726-97-3
|
C9H11N3O
|
|
Imidazo[1,2-a]pyrazin-3-ol, 2-methyl-, ion(1-) (9CI)
|
659727-06-7
|
C7H6N3O-
|
|
N,N-bis-(2-pyridylmethyl)pyromellitic diimide
|
659727-22-7
|
C22H14N4O4
|
|
4-(4-tert-Butyl-phenyl)-6-chloro-pyrimidine
|
659729-07-4
|
C14H15ClN2
|
|
4-chloro-6-(4'-(trifluoromethyl)phenyl)pyrimidine
|
659729-09-6
|
C11H6ClF3N2
|
|
2(1H)-Quinoxalinone, 8-methoxy-
|
659729-61-0
|
C9H8N2O2
|
|
2(1H)-Quinoxalinone, 8-hydroxy-
|
659729-62-1
|
C8H6N2O2
|
|
2(1H)-Quinoxalinone, 5-hydroxy-
|
659729-65-4
|
C8H6N2O2
|
|
2-Quinoxalinamine,8-methoxy-(9CI)
|
659729-71-2
|
C9H9N3O
|
|
5-Quinoxalinol, 3-amino-
|
659729-72-3
|
C8H7N3O
|
|
2-Quinoxalinamine,5-methoxy-(9CI)
|
659729-75-6
|
C9H9N3O
|
|
5-Quinoxalinol, 2-amino-
|
659729-76-7
|
C8H7N3O
|
|
2(1H)-Quinoxalinone,3-amino-8-methoxy-(9CI)
|
659729-78-9
|
C9H9N3O2
|
|
2(1H)-Quinoxalinone,3-amino-5-methoxy-(9CI)
|
659729-79-0
|
C9H9N3O2
|
|
2(1H)-Quinoxalinone,3-amino-8-hydroxy-(9CI)
|
659729-80-3
|
C8H7N3O2
|
|
3-Amino-5-hydroxyquinoxalin-2-(1H)-one
|
659729-85-8
|
C8H7N3O2
|
|
2-amino-8-hydroxyquinazolin
|
659730-14-0
|
C8H7N3O
|
|
7-hydroxyquinoline-3-carboxylic acid
|
659730-27-5
|
C10H7NO3
|
|
Amg 517
|
659730-32-2
|
C20H13F3N4O2S
|
|
(3-PYRROLIDIN-1-YLPHENYL)BORONIC ACID
|
659731-18-7
|
C10H14BNO2
|
|
5-CHLORO-2-FLUORO-4-IODOPYRIDINE
|
659731-48-3
|
C5H2ClFIN
|
|
2-Benzothiazolecarboxamide,4-hydroxy-(9CI)
|
659731-92-7
|
C8H6N2O2S
|
|
2-Benzothiazolecarboxamide,4-hydroxy-N,N-dimethyl-(9CI)
|
659731-95-0
|
C10H10N2O2S
|
|
4-Imidazolidinone,3-cyclohexyl-1-ethyl-2-thioxo-(9CI)
|
659734-00-6
|
C11H18N2OS
|
|
2-Propenamide,N-cyclohexyl-N-methyl-(9CI)
|
659734-36-8
|
C10H17NO
|
|
Cyclopentanecarboxamide, 2-amino-N-ethyl-, (1R,2S)-rel- (9CI)
|
659734-46-0
|
C8H16N2O
|
|
4-Penten-2-ynenitrile,5-hydroxy-4-(1-pyrrolidinyl)-(9CI)
|
659736-24-0
|
C9H10N2O
|
|
3',4'-DIHYDRO-6'-BROMO-SPIRO[IMIDAZOLIDINE-4,2(1'H)-NAPHTHALENE]-2,5-DIONE
|
659736-46-6
|
C12H11BrN2O2
|
|
2-Butyn-1-ol,4-(1-methyl-3-azabicyclo[3.1.0]hex-3-yl)-(9CI)
|
659736-74-0
|
C10H15NO
|
|
2-Butyn-1-ol,4-(3-azabicyclo[3.1.0]hex-3-yl)-(9CI)
|
659736-75-1
|
C9H13NO
|
|
2-Butyn-1-amine,4-(3-azabicyclo[3.1.0]hex-3-yl)-(9CI)
|
659736-77-3
|
C9H14N2
|
|
2-Butyn-1-ol,4-(2-methyl-3-azabicyclo[3.1.0]hex-3-yl)-(9CI)
|
659736-83-1
|
C10H15NO
|
|
2-AMINO-1,2,3,4-TETRAHYDRO-6-BROMO-2-NAPHTHALENE CARBOXYLIC ACID
|
659736-91-1
|
C11H12BrNO2
|
|
2-AMINO-7-BROMO-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBOXYLIC ACID
|
659736-95-5
|
C11H12BrNO2
|
|
1H-Isoindol-1-one, 2,3-dihydro-6-hydroxy- (9CI)
|
659737-57-2
|
C8H7NO2
|
|
Micraic acid A
|
659738-08-6
|
C22H32O3
|
|
(S)-3-(2-(dimethylamino)ethyl)-5-((2-oxooxazolidin-4-yl)methyl)-1H-indole-2-carboxylic acid
|
659738-69-9
|
C17H21N3O4
|
|
6-Methylpyridine-3-boronic Acid
|
659742-21-9
|
C6H8BNO2
|
|
Thiourea, (2-amino-6-benzothiazolyl)- (9CI)
|
659742-87-7
|
C8H8N4S2
|
|
Thiourea, (2-amino-5-benzothiazolyl)- (9CI)
|
659742-96-8
|
C8H8N4S2
|
|
Ethanimidamide, N-(2-amino-6-benzothiazolyl)- (9CI)
|
659743-44-9
|
C9H10N4S
|
|
Imidazo[1,5-a]pyridine-1-carboxaldehyde, 5,6,7,8-tetrahydro-3-methyl- (9CI)
|
659743-72-3
|
C9H12N2O
|
|
Isogarciniaxanthone E
|
659747-28-1
|
C28H32O6
|
|
1H-Isoindol-1-one,3-ethenyl-2-ethyl-2,3-dihydro-3-hydroxy-(9CI)
|
660391-79-7
|
C12H13NO2
|
|
Acetaldehyde, (2-ethyl-2,3-dihydro-3-oxo-1H-isoindol-1-ylidene)-, (2E)- (9CI)
|
660391-87-7
|
C12H11NO2
|
|
2-Morpholin-4-ylethylazide
|
660395-39-1
|
C6H12N4O
|
|
L-Proline, 4-hydroxy-5-oxo-, methyl ester (9CI)
|
660397-17-1
|
C6H9NO4
|
|
Isoquinoline, 7-(1-methylethoxy)- (9CI)
|
660398-05-0
|
C12H13NO
|
|
7-Isoquinolinol,8-bromo-(9CI)
|
660398-06-1
|
C9H6BrNO
|
|
3,4-Piperidinediol, 1-ethyl-, (3R,4R)-rel- (9CI)
|
660403-83-8
|
C7H15NO2
|
|
3,4-Piperidinediol, 1-propyl-, (3R,4R)-rel- (9CI)
|
660403-84-9
|
C8H17NO2
|
|
3,4-Piperidinediol, 6-methyl-1-(phenylmethyl)-, (3R,4R)-rel- (9CI)
|
660403-87-2
|
C13H19NO2
|
|
3,4-Piperidinediol, 4-methyl-1-(phenylmethyl)-, (3R,4R)-rel- (9CI)
|
660403-88-3
|
C13H19NO2
|
|
|
3,4-Piperidinediol, 5-methyl-1-(phenylmethyl)-, (3R,4R)-rel- (9CI)
|
660403-89-4
|
C13H19NO2
|
|
3,4-Piperidinediol,1-(2-hydroxyethyl)-,(3R,4R)-rel-(9CI)
|
660403-91-8
|
C7H15NO3
|
|
3,4-Piperidinediol, 1-(1-phenylethyl)-, (3R,4R)-rel- (9CI)
|
660403-92-9
|
C13H19NO2
|
|
1-BOC-4-(CYANOACETYL)PIPERIDINE
|
660406-84-8
|
C13H20N2O3
|
|
TERT-BUTYL 3-CYANOACETYL-1-PYRROLIDINECARBOXYLATE
|
660406-89-3
|
C12H18N2O3
|
|
3-Pyridinecarboxylicacid,1,2,3,4-tetrahydro-,ethylester(9CI)
|
660406-94-0
|
C8H13NO2
|
|
1H-Pyrazole-5-carboxylic acid, 4-bromo-1,3-dimethyl-, methyl ester
|
660408-08-2
|
C7H9BrN2O2
|
|
Acetaldehyde, O-(1,3-dioxobutyl)oxime, (1E)- (9CI)
|
660408-85-5
|
C6H9NO3
|
|
Acetaldehyde, O-[(2Z)-3-hydroxy-1-oxo-2-butenyl]oxime, (1E)- (9CI)
|
660408-90-2
|
C6H9NO3
|